You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
In vitro anti-Onchocerca ochengi activities of extracts and chromatographic fractions of Craterispermum laurinum and Morinda lucida
|
---|---|
Published in |
BMC Complementary Medicine and Therapies, September 2014
|
DOI | 10.1186/1472-6882-14-325 |
Pubmed ID | |
Authors |
Moses Samje, Jonathan Metuge, James Mbah, Brice Nguesson, Fidelis Cho-Ngwa |
Abstract |
Onchocerciasis caused by Onchocerca volvulus is the world's second leading infectious cause of blindness. There is currently no cure for the disease. Ivermectin, the current drug of choice is only microfilaricidal and suboptimal response to it is increasingly being reported. Thus, in contributing to the search for a cure, crude extracts and chromatographic fractions of Craterispermum laurinum and Morinda lucida were screened in vitro, against the bovine and most popular model of the parasite, Onchocerca ochengi. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 57 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 16% |
Student > Bachelor | 7 | 12% |
Researcher | 6 | 11% |
Student > Master | 4 | 7% |
Other | 3 | 5% |
Other | 10 | 18% |
Unknown | 18 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 10 | 18% |
Biochemistry, Genetics and Molecular Biology | 6 | 11% |
Medicine and Dentistry | 6 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 7% |
Chemistry | 4 | 7% |
Other | 7 | 12% |
Unknown | 20 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2020.
All research outputs
#17,725,418
of 22,761,738 outputs
Outputs from BMC Complementary Medicine and Therapies
#2,336
of 3,622 outputs
Outputs of similar age
#159,577
of 237,234 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#77
of 117 outputs
Altmetric has tracked 22,761,738 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,622 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 237,234 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.